摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(benzo[b]thien-2-yl)-1-bromohexane | 120772-89-6

中文名称
——
中文别名
——
英文名称
6-(benzo[b]thien-2-yl)-1-bromohexane
英文别名
2-(6-bromohexyl)-1-benzothiophene
6-(benzo[b]thien-2-yl)-1-bromohexane化学式
CAS
120772-89-6
化学式
C14H17BrS
mdl
——
分子量
297.259
InChiKey
NZWKDCOAUXRHBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    28.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-(benzo[b]thien-2-yl)-1-bromohexane 在 rose bengal 氧气magnesium 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 生成 4-(1-acetoxy-7-benzo[b]thien-2-yl-heptyl)-5-hydroxy-2(5H)-furanone
    参考文献:
    名称:
    Singlet oxygen oxidation of substituted furans to 5-hydroxy-2(5H)-furanone
    摘要:
    The conditions for the regiospecific singlet oxygen oxidation of various 2,4-disubstituted furans 9 to 4-substituted-2 (5H)-furanones 3 are developed. The presence of a C-2 substituent (e.g., trimethylsilyl, tert-butyldimethylsilyl, or tributylstannyl) in 9 is an absolute requirement for the formation of the 4-substituted-5-hydroxy-2(5H)-furanone regioisomer 3. When the C-2 substituent is triethylsilyl (TES) or TBDMS, however, apart from 3, the corresponding 5-trialkylsiloxy derivative 11 is also isolated in a significant amount. These silyl acetals are unexpectedly stable but can be hydrolyzed back to 3 on stirring with dilute acid. The formation of silyl acetals, to our knowledge, has never been reported in the singlet oxygen oxidation of (trialkylsilyl)furan. A plausible mechanism for their formation is proposed. The presence of a catalytic amount of water in the oxidation of 2-(trialkylsilyl)-4-substituted-furans not only eliminates the formation of the silyl acetals but also speeds up the rate of the oxidation process. Moreover, the oxidation can then be carried out at 0-degrees-C instead of at -78-degrees-C. Oxidation of 2-(1-hydroxyalkyl)-4-substituted-furans in the absence of a reducing agent gives little or no sign of 2,5-disubstituted-6-hydroxy-3(2H)-pyranone 23 but instead 26 selectively. Thus, the (1-hydroxy)alkyl group can be utilized as the trialkylsilyl or trialkylstannyl group in dictating the regioselectivity in the singlet oxygen oxidation of substituted furans.
    DOI:
    10.1021/jo00025a012
  • 作为产物:
    描述:
    参考文献:
    名称:
    Anti-inflammatory furanones
    摘要:
    新的具有抗炎、免疫抑制和抗增殖活性的5-羟基-2-呋喃酮化合物对治疗牛皮癣和调节钙稳态具有用处。
    公开号:
    US05134128A1
点击查看最新优质反应信息

文献信息

  • Anti-inflammatory furanone compounds
    申请人:ALLERGAN, INC.
    公开号:EP0429287A2
    公开(公告)日:1991-05-29
    The invention relates to compounds of the formula (A): wherein R₁ is C₁-C₁₇ alkyl or alkenyl having 1-5 unconjugated double bonds, carbocyclic aryl (C₁-C₁₇ alkyl or alkenyl having 1-5 unconjugated double bonds), or heteroaryl (C₁-C₁₇ alkyl or alkenyl having 1-5 unconjugated double bonds), cyclohexyl or cyclohexyl-(C₁-C₁₇ alkyl or alkenyl having 1-5 unconjugated double bonds); X is R₁ being linked to X through bond a; R₂ is hydrogen or C₁-C₄ alkyl; and R₃ is hydrogen or C₁-C₁₂ alkanoyl. Such compounds have anti-inflammatory, immunosuppressive and anti-proliferative activity and are useful in treating psoriasis and modifying calcium homeostasis. A compound of the invention is 4-[3,6-dihydro-6-hydroxy-5-(3-phenylpropyl)-2H-pyran-2-yl]-5-hydroxy-2-(5H)-furanone.
    本发明涉及式 (A) 的化合物: 其中 R₁ 是具有 1-5 个未共轭双键的 C₁-C₁₇ 烷基或烯基、碳环芳基(具有 1-5 个未共轭双键的 C₁-C₁₇ 烷基或烯基)、或杂芳基(具有 1-5 个未共轭双键的 C₁-C₁₇ 烷基或烯基)、环己基或环己基-(具有 1-5 个未共轭双键的 C₁-C₁₇ 烷基或烯基); X 是 R₁ 通过键 a 与 X 连接; R₂ 是氢或 C₁-C₄ 烷基;以及 R₃ 是氢或 C₁-C₁₂ 烷酰基。 此类化合物具有抗炎、免疫抑制和抗增殖活性,可用于治疗牛皮癣和调节钙平衡。本发明的一种化合物是 4-[3,6-二氢-6-羟基-5-(3-苯基丙基)-2H-吡喃-2-基]-5-羟基-2-(5H)-呋喃酮。
  • US5112853A
    申请人:——
    公开号:US5112853A
    公开(公告)日:1992-05-12
  • US5134128A
    申请人:——
    公开号:US5134128A
    公开(公告)日:1992-07-28
  • US5258400A
    申请人:——
    公开号:US5258400A
    公开(公告)日:1993-11-02
  • Anti-inflammatory furanones
    申请人:Allergan, Inc.
    公开号:US05134128A1
    公开(公告)日:1992-07-28
    New 5-hydroxy-2-furanone compounds having anti-inflammatory, immunosuppressive and anti-proliferative activity and are useful in treating psoriasis and modifying calcium homeostasis.
    新的具有抗炎、免疫抑制和抗增殖活性的5-羟基-2-呋喃酮化合物对治疗牛皮癣和调节钙稳态具有用处。
查看更多

同类化合物